Tag: regulatory strategy
-

From Pivotal Data to Approval: The Regulatory Review Strategy
This is Part 6 of The Drug Development Playbook. This article explains how to turn that data and your manufacturing story into an approval.
-

Clinical Development: Phases I to III
This is Part 5 in The Drug Development Playbook. In this article we move into clinical trials from phase I to III.
-

Preclinical Development and IND/CTA Readiness: making the candidate safe enough to test in people
This is Part 4 of The Drug Development Playbook. We talk about building nonclinical and CMC evidence that lets regulators say yes to first-in-human trials.